Published in Clin Trials on January 01, 2005
Subclinical hypothyroidism and the risk of coronary heart disease and mortality. JAMA (2010) 5.20
Statistical methods for the time-to-event analysis of individual participant data from multiple epidemiological studies. Int J Epidemiol (2010) 3.97
Job strain in relation to body mass index: pooled analysis of 160 000 adults from 13 cohort studies. J Intern Med (2011) 3.14
Vaginal progesterone in women with an asymptomatic sonographic short cervix in the midtrimester decreases preterm delivery and neonatal morbidity: a systematic review and metaanalysis of individual patient data. Am J Obstet Gynecol (2011) 2.95
Prospective meta-analysis using individual patient data in intensive care medicine. Intensive Care Med (2009) 2.93
Job strain as a risk factor for leisure-time physical inactivity: an individual-participant meta-analysis of up to 170,000 men and women: the IPD-Work Consortium. Am J Epidemiol (2012) 2.55
Evidence synthesis for decision making 3: heterogeneity--subgroups, meta-regression, bias, and bias-adjustment. Med Decis Making (2013) 2.43
Subclinical hyperthyroidism and the risk of coronary heart disease and mortality. Arch Intern Med (2012) 2.24
Clinical effectiveness of elective single versus double embryo transfer: meta-analysis of individual patient data from randomised trials. BMJ (2010) 2.19
Intravaginal practices, bacterial vaginosis, and HIV infection in women: individual participant data meta-analysis. PLoS Med (2011) 1.89
Subclinical thyroid dysfunction and the risk of heart failure events: an individual participant data analysis from 6 prospective cohorts. Circulation (2012) 1.79
Reasons or excuses for avoiding meta-analysis in forest plots. BMJ (2008) 1.69
Multivariate meta-analysis for non-linear and other multi-parameter associations. Stat Med (2012) 1.68
Quantifying, displaying and accounting for heterogeneity in the meta-analysis of RCTs using standard and generalised Q statistics. BMC Med Res Methodol (2011) 1.66
Job strain and tobacco smoking: an individual-participant data meta-analysis of 166,130 adults in 15 European studies. PLoS One (2012) 1.64
Hormonal contraception and the risk of HIV acquisition: an individual participant data meta-analysis. PLoS Med (2015) 1.61
Statistical analysis of individual participant data meta-analyses: a comparison of methods and recommendations for practice. PLoS One (2012) 1.50
Naftidrofuryl for intermittent claudication: meta-analysis based on individual patient data. BMJ (2009) 1.39
Individual participant data meta-analysis for a binary outcome: one-stage or two-stage? PLoS One (2013) 1.34
Investigating clinical heterogeneity in systematic reviews: a methodologic review of guidance in the literature. BMC Med Res Methodol (2012) 1.29
Job strain and alcohol intake: a collaborative meta-analysis of individual-participant data from 140,000 men and women. PLoS One (2012) 1.22
Systematic review of methods for individual patient data meta- analysis with binary outcomes. BMC Med Res Methodol (2014) 1.17
Vaginal progesterone vs. cervical cerclage for the prevention of preterm birth in women with a sonographic short cervix, previous preterm birth, and singleton gestation: a systematic review and indirect comparison metaanalysis. Am J Obstet Gynecol (2012) 1.15
Meta-analysis in medical research. Hippokratia (2010) 1.14
Bench-to-bedside review: avoiding pitfalls in critical care meta-analysis--funnel plots, risk estimates, types of heterogeneity, baseline risk and the ecologic fallacy. Crit Care (2008) 1.10
Acamprosate for alcohol dependence: a sex-specific meta-analysis based on individual patient data. Alcohol Clin Exp Res (2011) 1.10
Consensus-based recommendations for investigating clinical heterogeneity in systematic reviews. BMC Med Res Methodol (2013) 1.07
Combining multiple imputation and meta-analysis with individual participant data. Stat Med (2013) 1.07
Do corresponding authors take responsibility for their work? A covert survey. Clin Orthop Relat Res (2014) 1.04
Individual participant data meta-analyses should not ignore clustering. J Clin Epidemiol (2013) 1.00
Complications of lung resection and exercise capacity: a meta-analysis. Respir Med (2007) 0.98
Individual Participant Data (IPD) Meta-analyses of Randomised Controlled Trials: Guidance on Their Use. PLoS Med (2015) 0.96
Transcranial direct current stimulation for acute major depressive episodes: meta-analysis of individual patient data. Br J Psychiatry (2016) 0.96
Brief motivational interventions for college student drinking may not be as powerful as we think: an individual participant-level data meta-analysis. Alcohol Clin Exp Res (2015) 0.94
Multivariate meta-analysis using individual participant data. Res Synth Methods (2014) 0.94
Get real in individual participant data (IPD) meta-analysis: a review of the methodology. Res Synth Methods (2015) 0.93
Subclinical thyroid dysfunction and fracture risk: a meta-analysis. JAMA (2015) 0.92
Brain Network Organization in Focal Epilepsy: A Systematic Review and Meta-Analysis. PLoS One (2014) 0.89
A systematic review and meta-analysis of diagnostic and prognostic serum biomarkers of colorectal cancer. PLoS One (2014) 0.89
One-stage parametric meta-analysis of time-to-event outcomes. Stat Med (2010) 0.89
Combination of radiofrequency ablation with transarterial chemoembolization for hepatocellular carcinoma: a meta-analysis. Dig Dis Sci (2012) 0.88
Cognitive behavioral therapy age effects in child and adolescent anxiety: an individual patient data metaanalysis. Depress Anxiety (2013) 0.88
Gene-gene and gene-environment interactions in meta-analysis of genetic association studies. PLoS One (2015) 0.87
Mild fetal renal pelvis dilatation: much ado about nothing? Clin J Am Soc Nephrol (2008) 0.85
Inhaled Cannabis for Chronic Neuropathic Pain: A Meta-analysis of Individual Patient Data. J Pain (2015) 0.83
Survey finds that most meta-analysts do not attempt to collect individual patient data. J Clin Epidemiol (2012) 0.83
The project data sphere initiative: accelerating cancer research by sharing data. Oncologist (2015) 0.83
Adjuvant endocrine therapy for early breast cancer: a systematic review of the evidence for the 2014 Cancer Care Ontario systemic therapy guideline. Curr Oncol (2015) 0.83
Thyroid antibody status, subclinical hypothyroidism, and the risk of coronary heart disease: an individual participant data analysis. J Clin Endocrinol Metab (2014) 0.82
Complex association between alanine aminotransferase activity and mortality in general population: a systematic review and meta-analysis of prospective studies. PLoS One (2014) 0.82
Do Self-Management Interventions Work in Patients With Heart Failure? An Individual Patient Data Meta-Analysis. Circulation (2016) 0.82
Towards tailoring of self-management for patients with chronic heart failure or chronic obstructive pulmonary disease: a protocol for an individual patient data meta-analysis. BMJ Open (2014) 0.81
Subclinical hypothyroidism and cardiovascular risk: how to end the controversy. J Clin Endocrinol Metab (2013) 0.81
Two-stage meta-analysis of survival data from individual participants using percentile ratios. Stat Med (2012) 0.80
Individual patient data meta-analysis of survival data using Poisson regression models. BMC Med Res Methodol (2012) 0.80
Adjuvant chemotherapy for early female breast cancer: a systematic review of the evidence for the 2014 Cancer Care Ontario systemic therapy guideline. Curr Oncol (2015) 0.80
Combination of radiofrequency ablation with transarterial chemoembolization for hepatocellular carcinoma: a meta-analysis. Dig Dis Sci (2013) 0.80
Integrating and extending cohort studies: lessons from the eXtending Treatments, Education and Networks in Depression (xTEND) study. BMC Med Res Methodol (2013) 0.79
Distribution and epidemiological characteristics of published individual patient data meta-analyses. PLoS One (2014) 0.79
Statistical approaches to harmonize data on cognitive measures in systematic reviews are rarely reported. J Clin Epidemiol (2014) 0.79
Vaginal progesterone decreases preterm birth and neonatal morbidity and mortality in women with a twin gestation and a short cervix: An updated meta-analysis of individual patient data. Ultrasound Obstet Gynecol (2017) 0.78
Survival dimensionality reduction (SDR): development and clinical application of an innovative approach to detect epistasis in presence of right-censored data. BMC Bioinformatics (2010) 0.78
Progestogens to prevent preterm birth in twin pregnancies: an individual participant data meta-analysis of randomized trials. BMC Pregnancy Childbirth (2012) 0.78
Carbapenems versus other beta-lactams in treating severe infections in intensive care: a systematic review of randomised controlled trials. Eur J Clin Microbiol Infect Dis (2008) 0.77
Accounting for biases when linking empirical studies and simulation models. Med Decis Making (2012) 0.77
Do self-management interventions in COPD patients work and which patients benefit most? An individual patient data meta-analysis. Int J Chron Obstruct Pulmon Dis (2016) 0.77
Instrumental variable meta-analysis of individual patient data: application to adjust for treatment non-compliance. BMC Med Res Methodol (2011) 0.77
Association between p53 Pro72Arg polymorphism and prostate cancer risk: a meta-analysis. J Biomed Res (2011) 0.77
GSTM1 null genotype contributes to increased risk of male infertility: a meta-analysis. J Assist Reprod Genet (2012) 0.77
Systematic review and meta-analysis: a primer. Int J Sports Phys Ther (2012) 0.76
Psychosocial interventions for children exposed to traumatic events in low- and middle-income countries: study protocol of an individual patient data meta-analysis. Syst Rev (2014) 0.76
Comparison of coronary DES and BMS in octogenarians: A systematic review and meta-analysis. J Geriatr Cardiol (2013) 0.76
A scoping review of indirect comparison methods and applications using individual patient data. BMC Med Res Methodol (2016) 0.76
Comparative safety and effectiveness of cognitive enhancers for Alzheimer's dementia: protocol for a systematic review and individual patient data network meta-analysis. BMJ Open (2016) 0.76
Epistasis Test in Meta-Analysis: A Multi-Parameter Markov Chain Monte Carlo Model for Consistency of Evidence. PLoS One (2016) 0.76
Long-term antipsychotic treatment in schizophrenia: systematic review and network meta-analysis of randomised controlled trials. BJPsych Open (2016) 0.75
Use of heparins in patients with cancer: individual participant data meta-analysis of randomised trials study protocol. BMJ Open (2016) 0.75
Evidence and controversies regarding the screening for subclinical hypothyroidism in patients with cardiovascular disease. J Thorac Dis (2016) 0.75
White matter abnormalities at a regional and voxel level in focal and generalized epilepsy: A systematic review and meta-analysis. Neuroimage Clin (2016) 0.75
Mortality Rates Among Substance Use Disorder Participants in Clinical Trials: Pooled Analysis of Twenty-Two Clinical Trials Within the National Drug Abuse Treatment Clinical Trials Network. J Subst Abuse Treat (2016) 0.75
Meta-analyses triggered by previous (false-)significant findings: problems and solutions. Syst Rev (2015) 0.75
Contributions of upper gut hormones and motility to the energy intake-suppressant effects of intraduodenal nutrients in healthy, lean men - a pooled-data analysis. Physiol Rep (2016) 0.75
A systematic review with attempted network meta-analysis of asthma therapy recommended for five to eighteen year olds in GINA steps three and four. BMC Pulm Med (2012) 0.75
Propensity Score-Based Approaches to Confounding by Indication in Individual Patient Data Meta-Analysis: Non-Standardized Treatment for Multidrug Resistant Tuberculosis. PLoS One (2016) 0.75
A comparison of analytic approaches for individual patient data meta-analyses with binary outcomes. BMC Med Res Methodol (2017) 0.75
Meta-analysis using individual participant data: one-stage and two-stage approaches, and why they may differ. Stat Med (2016) 0.75
Types of studies and research design. Indian J Anaesth (2016) 0.75
Text2PreventCVD: protocol for a systematic review and individual participant data meta-analysis of text message-based interventions for the prevention of cardiovascular diseases. BMJ Open (2016) 0.75
Dose-response meta-analysis of differences in means. BMC Med Res Methodol (2016) 0.75
Serious Adverse Events with Bevacizumab or Ranibizumab for Age-related Macular Degeneration: Meta-analysis of Individual Patient Data. Ophthalmol Retina (2017) 0.75
Malaria, malnutrition, and birthweight: A meta-analysis using individual participant data. PLoS Med (2017) 0.75
Multiple imputation by chained equations for systematically and sporadically missing multilevel data. Stat Methods Med Res (2016) 0.75
Measuring inconsistency in meta-analyses. BMJ (2003) 128.20
Quantifying heterogeneity in a meta-analysis. Stat Med (2002) 83.16
Practical methods for incorporating summary time-to-event data into meta-analysis. Trials (2007) 14.51
Association of dietary, circulating, and supplement fatty acids with coronary risk: a systematic review and meta-analysis. Ann Intern Med (2014) 12.79
C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet (2009) 11.81
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev (2015) 11.05
Methods to increase response to postal and electronic questionnaires. Cochrane Database Syst Rev (2009) 10.85
Major lipids, apolipoproteins, and risk of vascular disease. JAMA (2009) 10.58
Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies. Lancet (2011) 9.07
How should meta-regression analyses be undertaken and interpreted? Stat Med (2002) 8.96
Endovascular versus open repair of abdominal aortic aneurysm. N Engl J Med (2010) 7.83
Tools for assessing quality and susceptibility to bias in observational studies in epidemiology: a systematic review and annotated bibliography. Int J Epidemiol (2007) 7.00
Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ (2011) 6.80
Controlling the risk of spurious findings from meta-regression. Stat Med (2004) 6.80
C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med (2012) 6.39
A re-evaluation of random-effects meta-analysis. J R Stat Soc Ser A Stat Soc (2009) 5.81
Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality. JAMA (2009) 5.63
Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA (2005) 5.60
Publication bias in clinical trials due to statistical significance or direction of trial results. Cochrane Database Syst Rev (2009) 5.57
Are missing outcome data adequately handled? A review of published randomized controlled trials in major medical journals. Clin Trials (2004) 5.26
Assessment of cumulative evidence on genetic associations: interim guidelines. Int J Epidemiol (2007) 4.96
Evaluation of networks of randomized trials. Stat Methods Med Res (2007) 4.70
Lipoprotein-associated phospholipase A(2) and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies. Lancet (2010) 4.46
Long-term interleukin-6 levels and subsequent risk of coronary heart disease: two new prospective studies and a systematic review. PLoS Med (2008) 4.34
Interpretation of random effects meta-analyses. BMJ (2011) 4.32
Meta-analyses involving cross-over trials: methodological issues. Int J Epidemiol (2002) 4.30
Safety and effectiveness of recombinant human bone morphogenetic protein-2 for spinal fusion: a meta-analysis of individual-participant data. Ann Intern Med (2013) 4.02
Lipid-related markers and cardiovascular disease prediction. JAMA (2012) 3.91
Investigating patient exclusion bias in meta-analysis. Int J Epidemiol (2004) 3.90
Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). Eur Heart J (2005) 3.89
A systematic review and meta-analysis of the literature: chemotherapy and surgery versus surgery alone in non-small cell lung cancer. J Thorac Oncol (2006) 3.78
Association between C reactive protein and coronary heart disease: mendelian randomisation analysis based on individual participant data. BMJ (2011) 3.65
Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data. Lancet (2007) 3.53
Risks and benefits of omega 3 fats for mortality, cardiovascular disease, and cancer: systematic review. BMJ (2006) 3.47
A sustained mortality benefit from screening for abdominal aortic aneurysm. Ann Intern Med (2007) 3.27
A road map for efficient and reliable human genome epidemiology. Nat Genet (2006) 3.21
To IPD or not to IPD? Advantages and disadvantages of systematic reviews using individual patient data. Eval Health Prof (2002) 3.11
Abdominal aortic aneurysm expansion: risk factors and time intervals for surveillance. Circulation (2004) 3.07
Extending DerSimonian and Laird's methodology to perform multivariate random effects meta-analyses. Stat Med (2010) 3.07
Endovascular or open repair strategy for ruptured abdominal aortic aneurysm: 30 day outcomes from IMPROVE randomised trial. BMJ (2014) 2.98
Recent developments in meta-analysis. Stat Med (2008) 2.97
Bias modelling in evidence synthesis. J R Stat Soc Ser A Stat Soc (2009) 2.74
Seven haemostatic gene polymorphisms in coronary disease: meta-analysis of 66,155 cases and 91,307 controls. Lancet (2006) 2.72
Adjusting for partially missing baseline measurements in randomized trials. Stat Med (2005) 2.70
Graphical tools for network meta-analysis in STATA. PLoS One (2013) 2.66
Methodological challenges in online trials. J Med Internet Res (2009) 2.64
Synthesizing evidence on complex interventions: how meta-analytical, qualitative, and mixed-method approaches can contribute. J Clin Epidemiol (2013) 2.59
Predicting the extent of heterogeneity in meta-analysis, using empirical data from the Cochrane Database of Systematic Reviews. Int J Epidemiol (2012) 2.58
Admission avoidance hospital at home. Cochrane Database Syst Rev (2008) 2.55
Strengthening the reporting of genetic association studies (STREGA): an extension of the strengthening the reporting of observational studies in epidemiology (STROBE) statement. J Clin Epidemiol (2009) 2.45
Poorer self assessed health in a prospective study of men with screen detected abdominal aortic aneurysm: a predictor or a consequence of screening outcome? J Epidemiol Community Health (2004) 2.42
STrengthening the REporting of Genetic Association Studies (STREGA): an extension of the STROBE statement. PLoS Med (2009) 2.39
Electric fans for reducing adverse health impacts in heatwaves. Cochrane Database Syst Rev (2012) 2.35
Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol (2013) 2.34
Review of statistical methods for analysing healthcare resources and costs. Health Econ (2010) 2.27
A case study of multiple-treatments meta-analysis demonstrates that covariates should be considered. J Clin Epidemiol (2009) 2.26
Regression dilution methods for meta-analysis: assessing long-term variability in plasma fibrinogen among 27,247 adults in 15 prospective studies. Int J Epidemiol (2006) 2.22
Meta-analysis of studies of alcohol and breast cancer with consideration of the methodological issues. Cancer Causes Control (2006) 2.17
Relative and absolute risk of colorectal cancer for individuals with a family history: a meta-analysis. Eur J Cancer (2005) 2.16
Genome-wide association studies, field synopses, and the development of the knowledge base on genetic variation and human diseases. Am J Epidemiol (2009) 2.15
Multivariable Mendelian randomization: the use of pleiotropic genetic variants to estimate causal effects. Am J Epidemiol (2015) 2.14
Treating individuals 4: can meta-analysis help target interventions at individuals most likely to benefit? Lancet (2005) 2.09
Array CGH in patients with learning disability (mental retardation) and congenital anomalies: updated systematic review and meta-analysis of 19 studies and 13,926 subjects. Genet Med (2009) 2.09
Use of allele scores as instrumental variables for Mendelian randomization. Int J Epidemiol (2013) 2.06
Surrogate endpoints for overall survival in chemotherapy and radiotherapy trials in operable and locally advanced lung cancer: a re-analysis of meta-analyses of individual patients' data. Lancet Oncol (2013) 1.99
Characteristics of meta-analyses and their component studies in the Cochrane Database of Systematic Reviews: a cross-sectional, descriptive analysis. BMC Med Res Methodol (2011) 1.97
Endovascular repair of aortic aneurysm in patients physically ineligible for open repair. N Engl J Med (2010) 1.92
Conceptual and technical challenges in network meta-analysis. Ann Intern Med (2013) 1.92
Clustering by health professional in individually randomised trials. BMJ (2005) 1.85
STrengthening the REporting of Genetic Association studies (STREGA)--an extension of the STROBE statement. Eur J Clin Invest (2009) 1.82
Avoiding bias from weak instruments in Mendelian randomization studies. Int J Epidemiol (2011) 1.75
Evaluation of inconsistency in networks of interventions. Int J Epidemiol (2013) 1.72
Obstacles and opportunities in meta-analysis of genetic association studies. Genet Med (2005) 1.71
Seven lipoprotein lipase gene polymorphisms, lipid fractions, and coronary disease: a HuGE association review and meta-analysis. Am J Epidemiol (2008) 1.71
Use of Mendelian randomisation to assess potential benefit of clinical intervention. BMJ (2012) 1.70
Quantifying, displaying and accounting for heterogeneity in the meta-analysis of RCTs using standard and generalised Q statistics. BMC Med Res Methodol (2011) 1.66
Impact and costs of incentives to reduce attrition in online trials: two randomized controlled trials. J Med Internet Res (2011) 1.66
Interventions to improve the use of systematic reviews in decision-making by health system managers, policy makers and clinicians. Cochrane Database Syst Rev (2012) 1.66
Assessing the impact of drinking water and sanitation on diarrhoeal disease in low- and middle-income settings: systematic review and meta-regression. Trop Med Int Health (2014) 1.64
Hygiene and health: systematic review of handwashing practices worldwide and update of health effects. Trop Med Int Health (2014) 1.63
The emergence of networks in human genome epidemiology: challenges and opportunities. Epidemiology (2007) 1.61
On-line randomized controlled trial of an internet based psychologically enhanced intervention for people with hazardous alcohol consumption. PLoS One (2011) 1.61
Flexible parametric models for random-effects distributions. Stat Med (2008) 1.61
Systematic reviews of genetic association studies. Human Genome Epidemiology Network. PLoS Med (2009) 1.60
Instrumental variable analysis with a nonlinear exposure-outcome relationship. Epidemiology (2014) 1.58
Avoiding hospital admission through provision of hospital care at home: a systematic review and meta-analysis of individual patient data. CMAJ (2009) 1.58
The DYD-RCT protocol: an on-line randomised controlled trial of an interactive computer-based intervention compared with a standard information website to reduce alcohol consumption among hazardous drinkers. BMC Public Health (2007) 1.56
Using published data in Mendelian randomization: a blueprint for efficient identification of causal risk factors. Eur J Epidemiol (2015) 1.51
Statistical analysis of individual participant data meta-analyses: a comparison of methods and recommendations for practice. PLoS One (2012) 1.50
The use of random effects models to allow for clustering in individually randomized trials. Clin Trials (2005) 1.50
The association between the peroxisome proliferator-activated receptor-gamma2 (PPARG2) Pro12Ala gene variant and type 2 diabetes mellitus: a HuGE review and meta-analysis. Am J Epidemiol (2010) 1.49
Strengthening the reporting of genetic association studies (STREGA): an extension of the STROBE Statement. Hum Genet (2009) 1.47
Bias in causal estimates from Mendelian randomization studies with weak instruments. Stat Med (2011) 1.44